Related Experiment Video
Updated: Jul 7, 2026
09:14
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
10.8K
Some assembly required: a single-RNA vaccine against enterovirus-D68.
Noah Pollack1, William T Jackson1
1Department of Microbiology and Immunology and Center for Pathogen Research, University of Maryland School of Medicine, 685 W. Baltimore Avenue, Baltimore, MD 21201, USA.
Trends in Pharmacological Sciences
|November 12, 2024
Summary
A novel single-RNA vaccine shows promise against enterovirus-D68, a virus causing severe paralysis in children. This vaccine effectively generated cross-neutralizing antibodies in animal models, offering hope for future prevention strategies.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Enterovirus-D68 (EV-D68) is a significant respiratory pathogen responsible for severe paralytic disease in children.
- Current therapeutic strategies for EV-D68 infection are limited, highlighting the need for effective preventative measures.
Purpose of the Study:
- To develop and evaluate a single-RNA-based vaccine candidate against enterovirus-D68.
- To assess the vaccine's immunogenicity and its ability to induce broadly cross-neutralizing antibodies.
Main Methods:
- Development of a single-RNA vaccine targeting enterovirus-D68.
- Immunization of animal models, including mice and macaque monkeys.
- Evaluation of antibody responses, focusing on neutralization breadth and potency.
Main Results:
- The single-RNA vaccine successfully induced robust antibody responses in both mice and macaque models.
- The generated antibodies demonstrated broad cross-neutralizing activity against various enterovirus-D68 strains.
- No significant adverse effects were reported in the vaccinated animal models.
Conclusions:
- A single-RNA-based vaccine is a promising strategy for preventing enterovirus-D68 infection.
- The vaccine's ability to elicit broadly cross-neutralizing antibodies suggests potential for broad protection against EV-D68-associated diseases.
- Further research and clinical trials are warranted to explore the vaccine's efficacy in humans.
Related Concept Videos
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:28Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...